Complement Protein C3 Binding to Mycobacterium tuberculosis Is Initiated by the Classical Pathway in Human Bronchoalveolar Lavage Fluid

Infection and Immunity

Volumn 72, Issue 5, 2004, Pages 2564-2573

  Ferguson, J Scott ^a,c   Weis, Jeremy J ^a,b,e   Martin, Jennifer L ^a   Schlesinger, Larry S ^a,b,c,d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c Division of Pulmonary   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR I;

ARTICLE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; HOST; HUMAN; IMMUNE RESPONSE; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

BRONCHOALVEOLAR LAVAGE FLUID; COMPLEMENT C3; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; HUMANS; MACROPHAGES, ALVEOLAR; MYCOBACTERIUM TUBERCULOSIS; OPSONIN PROTEINS; PHAGOCYTOSIS; PROTEIN BINDING;

EID: 2142698651     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.5.2564-2573.2004     Document Type: Article

References (54)

1. Actor, J. K., E. Breij, R. A. Wetsel, H. Hoffmann, R. L. Hunter, Jr., and C. Jagannath. 2001. A role for complement C5 in organism containment and granulomatous response during murine tuberculosis Scand. J. Immunol. 53:464-474.
2. Armstrong, J. A., and P. D. Hart. 1971. Response of cultured macrophges to Mycobacterium tuberculosis, with observations on fusion of lysosomes with phagosomes. J. Exp. Med. 134:713-740.
3. Bardana, E. J. J., J. K. McClatchy, R. S. Farr, and P. Minden. 1973. Universal occurrence of antibodies to tubercle bacilli in sera from non-tuberculous and tuberculous individuals. Clin. Exp. Immunol. 13:65-77.
4. Berger, M. 1990. Third component of human complement: C3. Methods Enzymol. 184:619-628.
5. Bohlson, S. S., J. A. Strasser, J. J. Bower, J. S. Schorev. 2001. Role of complement in Mycobacterium avium pathogenesis: in vivo and in vitro analyses of the host response to infection in the absence of complement component C3. Infect. Immun. 69:7729-7735.
6. Cole, F. S., W. J. J. Matthews, T. H. Rossing, D. J. Gash, N. A. Lichtenberg, and J. E. Pennington. 1983 Complement biosynthesis by human bronchoalveolar macrophages. Clin. Immunol. Immunopathol. 27:153-159
7. Coonrod, J. D., and K. Yoneda. 1981. Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae. Rev. Infect. Dis. 3:310-322.
8. Cywes, C., N. L. Godenir, H. C. Hoppe, R. R. Scholle, L. M. Steyn, R. E. Kirsch, and M. R. Ehlers. 1996. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect. Immun. 64:5373-5383.
9. Douvas, G. S., E. M. Berger, J. E. Repine, and A. J. Crowle. 1986. Natural mycobacteriostatic activity in human monocyte-derived adherent cells. Am. Rev. Respir. Dis. 134:44-48.
10. Ernst, J. D. 1998. Macrophage receptors for Mycobacterium tuberculosis. Infect. Immun. 66:1277-1281.
11. Ferguson, J. S., D. R. Voelker, F. X. McCormack, and L. S. Schlesinger. 1999. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J. Immunol. 163:312-321.
12. Figueroa, J. E., and P. Densen. 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:359-395.
13. Giclas, P. C., T. E. King, S. L. Baker, J. Russo, and P. M. Henson. 1987. Complement activity in normal rabbit bronchoalveolar fluid. Description of an inhibitor of C3 activation. Am. Rev. Respir. Dis. 135:403-411.
14. Greffard, A., J. J. Bourgarit, S. le Maho, and C. R. Lambre. 1987. Determination of the complement component C2 by ELISA in human serum and bronchoalveolar lavage fluids. Immunol. Lett. 15:145-151.
15. Hetland, G., H. G. Wiker, K. Hogasen, B. Hamasur, S. B. Svenson, and M. Harboe. 1998. Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis. Clin. Diagn. Lab. Immunol. 5:211-218.
16. Hirsch, C. S., J. J. Ellner, D. G. Russell, and E. A. Rich. 1994. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J. Immunol. 152:743-753.
17. Hoal-Van Helden, E. G., J. Epstein, T. C. Victor, D. Hon, L. A. Lewis, N. Beyers, D. Zurakowski, A. B. Ezekowitz, and P. D. Van Helden. 1999. Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr. Res. 45:459-464.
18. Horwitz, M. A., and S. C. Silverstein. 1980. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. J. Clin. Investig. 65:82-94.
19. Hu, C., T. Mayadas-Norton, K. Tanaka, J. Chan, and P. Salgame. 2000. Mycobacterium tuberculosis infection in complement receptor 3-deficient mice. J. Immunol. 165:2596-2602.
20. Hunninghake, G. W., J. E. Godek, O. Kawanami, V. J. Ferrans, and R. G. Crystal. 1979. Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am. J. Pathol. 97:149-206.
21. Jagannath, C., H. Hoffmann, E. Sepulveda, J. K. Actor, R. A. Wetsel, and R. L. Hunter. 2000. Hypersusceptibility of A/J mice to tuberculosis is in part due to a deficiency of the fifth complement component (C5). Scand. J. Immunol. 52:369-379.
22. Klickstein, L. B., S. F. Barbashov, T. Liu, R. M. Jack, and A. Nicholson-Weller. 1997. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. Immunity 7:345-355.
23. Kolb, W. P., L. M. Kolb, R. A. Wetsel, W. R. Rogers, and J. O. Shaw. 1981. Quantitation and stability of the fifth component of complement (C5) in bronchoalveolar lavage fluids obtained from non-human primates. Am. Rev. Respir. Dis. 123:226-231.
24. Law, S. K., N. A. Lichtenberg, and R. P. Levine. 1979. Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces. J. Immunol. 123:1388-1394.
25. Leemans, J. C., N. P. Jugemans, S. Florquin, N. van Rooijen, M. J. Vervoordeldonk, A. Verbon, S. J. van Deventer, and T. van der Poll. 2001. Depletion of alveolar macrophages exerts protective effects in pulmonary tuberculosis in mice. J. Immunol. 166:4604-4611.
26. Lelst-Welsh, P., and A. B. Bjornson. 1982. Immunoglobulin-independent utilization of the classical complement pathway in opsonophagocytosis of Escherichia coli by human peripheral leukocytes. J. Immunol. 128:2643-2651.
27. Matsushita, M., M. Kuraya, N. Hamasaki, M. Tsujimura, H. Shiraki, and T. Fujila. 2002. Activation of the lectin complement pathway by H-ficolin (Hakata antigen). J. Immunol. 168:3502.
28. Mintz, C. S., P. I. Arnold, W. Johnson, and D. R. Schultz. 1995. Antibody-independent binding of complement component C1q by Legionella pneumophila. Infect. Immun. 63:4939-4943.
29. Mueller-Ortiz, S. L., A. R. Wanger, and S. J. Norris. 2001. Mycobacterial protein HbhA binds human complement component C3. Infect. Immun. 69:7501-7511.
30. Muller-Eberhard, H. J., M. J. Polley, and M. A. Calcott. 1967. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. J. Exp. Med. 125:359-380.
31. Myones, B. L., J. G. Dalzell, N. Hogg, and G. D. Ross. 1988. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J. Clin. Investig. 82:640-651.
32. Neth, O., D. L. Jack, A. W. Dodds, H. Holzel, N. J. Klein, and M. W. Turner. 2000. Mannose-binding lectin binds to a range of clinically relevant micro-organisms and promotes complement deposition. Infect. Immun. 68:688-693.
33. Pangburn, M. K. 1986. The alternative pathway, p. 45-62. In G. D. Ross (ed.), Immunobiology of the complement system: an introduction for research and clinical medicine. Academic Press, Inc., Orlando, Fla.
34. Petersen, S. V., S. Thiel, L. Jensen, T. Vorup-Jensen, C. Koch, and J. C. Jensenius. 2000. Control of the classical and the MBL pathway of complement activation. Mol. Immunol. 37:803-811.
35. Polotsky, V. Y., J. T. Belisle, K. Mikusova, R. A. Ezekowitz, and K. A. Jolner. 1997. Interaction of human mannose-binding protein with Mycobacterium avium. J. Infect. Dis. 175:1159-1168.
36. Ramanathan, V. D., J. Curtis, and J. L. Turk. 1980. Activation of the alternative pathway of complement by mycobacteria and cord factor. Infect. Immun. 29:30-35.
37. Reading, P. C., L. S. Morey, E. C. Crouch, and E. M. Anders. 1997. Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice. J. Virol. 71:8204-8212.
38. Ross, G. D. 1986. Opsonization and membrane complement receptors, p. 87-114. In G. D. Ross (ed.), Immunobiology of the complement system: an introduction for research and clinical medicine. Academic Press, Inc., Orlando. Fla.
39. Sai Baba, K. S., K. D. Moudgil, R. C. Jain, and L. M. Srivastava. 1990. Complement activation in pulmonary tuberculosis. Tubercle 71:103-107.
40. Schlesinger, L. S. 1993. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150:2920-2930.
41. Schlesinger, L. S., C. G. Bellinger-Kawahara, N. R. Payne, and M. A. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144:2771-2790.
42. Schlesinger, L. S., and M. A. Horwitz. 1994. A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes. Infect. Immun. 62:280-299.
43. Schorey, J. S., M. C. Carroll, and E. J. Brown. 1997. A macrophage invasion mechanism of pathogenic mycobacteria. Science 277:1091-1093.
44. Sim, R. B., T. M. Twose, D. S. Paterson, and E. Sim. 1981. The covalent-binding reaction of complement component C3. Biochem. J. 193:115-127.
45. Stokes, R. W., I. D. Haidl, W. A. Jefferies, and D. P. Speert. 1993. Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J. Immunol. 151:7067-7076.
46. Stokes, R. W., L. M. Thorson, and D. P. Speert. 1998. Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient. J. Immunol. 160:5514-5521.
47. Strunk, R. C., D. M. Eidlen, and R. J. Mason. 1988. Pulmonary alveolar type II epithelial cells synthesize and secrete proteins of the classical and alternative complement pathways. J. Clin. Investig. 81:1419-1426.
48. Tan, S. M., M. C. Chung, O. L. Kon, S. Thiel, S. H. Lee, and J. Lu. 1996. Improvements on the purification of mannan-binding lectin and demonstration of its Ca(2+)-independent association with a C1s-like serine protease. Biochem. J. 319:329-332.
49. Thiel, S., T. Vorup-Jensen, C. M. Stover, W. Schwaeble, S. B. Laursen, K. Poulsen, A. C. Willis, P. Eggleton, S. Hansen, U. Holmskov, K. B. Reid, and J. C. Jensenius. 1997. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386:506-510.
50. Watford, W. T., A. J. Ghio, and J. R. Wright. 2000. Complement-mediated host defense in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L790-L798.
51. Watford, W. T., J. R. Wright, C. G. Hester, H. Jiang, and M. M. Frank. 2001. Surfactant protein A regulates complement activation. J. Immunol. 167:6593-6600.
52. Whaley, K. 1985. Measurement of complement, p. 77-139. In K. Whaley (ed.), Methods in complement for clinical immunologists. Churchill Livingstone, New York, N.Y.
53. Wong, N. K. H., M. Kojima, J. Dobo, G. Ambrus, and R. B. Sim. 1999. Activities of the MBL-associated serine proteases (MASPs) and their regulation by natural inhibitors. Mol. Immunol. 36:853-861.
54. Zhang, Y., C. Suankratay, X. H. Zhang, T. F. Lint, and H. Gewurz. 1999. Lysis via the lectin pathway of complement activation: minireview and lectin pathway enhancement of endotoxin-initiated hemolysis. Immunopharmacology 42:81-90.